Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

ClinicalTrials.gov ID: NCT03540160

Public ClinicalTrials.gov record NCT03540160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study of the long term safety of serlopitant for the treatment of pruritus in adults.

Study identification

NCT ID
NCT03540160
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vyne Therapeutics Inc.
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2018 (Actual)
Primary completion
Apr 8, 2020 (Actual)
Completion
Jun 17, 2020 (Actual)
Last update posted
May 20, 2021

2018 – 2020

United States locations

U.S. sites
46
U.S. states
25
U.S. cities
45
Facility City State ZIP Site status
Study Site 504 Birmingham Alabama 35233 —
Study Site 204 Fremont California 94538 —
Study Site 383 North Hollywood California 91606 —
Study Site 356 San Diego California 92108 —
Study Site 514 Santa Ana California 92701 —
Study Site 501 Aventura Florida 33180 —
Study Site 210 Coral Gables Florida 33134 —
Study Site 534 Fort Lauderdale Florida 33316 —
Study Site 531 Miami Florida 33155 —
Study Site 222 North Miami Beach Florida 33162 —
Study Site 510 Newnan Georgia 30263 —
Study Site 388 Skokie Illinois 60077 —
Study Site 228 Louisville Kentucky 40202 —
Study Site 527 New Orleans Louisiana 70115 —
Study Site 525 Glenn Dale Maryland 20769 —
Study Site 506 Ann Arbor Michigan 48103 —
Study Site 515 Detroit Michigan 48202 —
Study Site 371 Saint Joseph Missouri 64506 —
Study Site 528 St Louis Missouri 63110 —
Study Site 227 Omaha Nebraska 68144 —
Study Site 526 Henderson Nevada 89052 —
Study Site 201 East Windsor New Jersey 08520 —
Study Site 529 Verona New Jersey 07044-2946 —
Study Site 507 Brooklyn New York 11203 —
Study Site 508 Buffalo New York 14221 —
Study Site 500 New York New York 10025 —
Study Site 517 New York New York 10075 —
Study Site 341 High Point North Carolina 27262 —
Study Site 516 Bexley Ohio 43209 —
Study Site 509 Cleveland Ohio 44106 —
Study Site 524 Dublin Ohio 43016 —
Study Site 112 Tulsa Oklahoma 74136 —
Study Site 523 Philadelphia Pennsylvania 19104 —
Study Site 522 Pittsburgh Pennsylvania 15213 —
Study Site 345 Johnston Rhode Island 02919 —
Study Site 343 Spartanburg South Carolina 29303 —
Study Site 511 Knoxville Tennessee 37317 —
Study Site 365 Austin Texas 78745 —
Study Site 520 Bellaire Texas 77401 —
Study Site 502 Dallas Texas 75231 —
Study Site 224 Houston Texas 77004 —
Study Site 359 Pflugerville Texas 78660 —
Study Site 226 Webster Texas 77598 —
Study Site 336 Richmond Virginia 23220 —
Study Site 806 Spokane Washington 99202 —
Study Site 532 Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03540160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03540160 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →